Carelon, the health services subsidiary of Indianapolis-based insurance firm Elevance Health, moved to acquire CareBridge.

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Elevance Health (ELV – Research Report), with a ...

Bernstein lowered the firm’s price target on Elevance Health (ELV) to $549 from $665 and keeps an Outperform rating on the shares. The ...

We recently compiled a list of the 8 Most Undervalued Value Stocks To Buy According To Analysts. In this article, we are ...

FanDuel Sports Network – formerly known as Bally Sports Indiana – enters its 29th season as the official home of the Indiana Pacers and is scheduled to bring fans comprehensive coverage of 76 regular ...

Elevance Health (NYSE:ELV – Get Free Report) had its price objective dropped by stock analysts at TD Cowen from $589.00 to $484.00 in a report released on Monday, Benzinga reports. The brokerage ...

Elevance Health Inc. is seeking to sell investment-grade bonds as the big US insurer’s shares have fallen the most since 2020 ...

Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus ...

CEO Jim Davis said the company is on track to close eight lab acquisition deals this year, though he added that it is now in an "integration and digestion" phase.

CEO Gail Boudreaux says cut points are a large factor driving the decline of plans rated four stars or higher.

On Friday, Elevance Health Inc (ELV) stock saw a decline, ending the day at $430.77 which represents a decrease of $-13.58 or -3.06% from the prior close of $444.35. The stock opened at $436.44 and ...

The emails from inside a physician practice owned by UnitedHealth Group sounded cheery, but were all business.